...
首页> 外文期刊>HPB: the official journal of the International Hepato Pancreato Biliary Association >Does fibrin glue sealant decrease the rate of anastomotic leak after a pancreaticoduodenectomy? Results of a prospective randomized trial
【24h】

Does fibrin glue sealant decrease the rate of anastomotic leak after a pancreaticoduodenectomy? Results of a prospective randomized trial

机译:纤维蛋白胶密封剂会降低胰十二指肠切除术后的吻合口漏率吗?前瞻性随机试验的结果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background The aim of this study was to evaluate the effect of topical fibrin glue applied externally to all anastomoses after a pancreaticoduodenectomy (PD) on drain lipase levels, anastomotic leaks, complication rates and length of hospital stay. Methods A standardized non-pylorus preserving PD was performed with or without fibrin glue applied to each anastomosis. Results Fifty-seven patients were randomized: 32 with and 25 without TISSEEL. There were no statistical differences in each group with respect to drain lipase levels (high 40% versus 43%, P = 0.794), complications including gastric or biliary leaks (24% versus 28%, P = 1.00), wound infection (16% versus 9%, P = 0.28) and a Clavien score of 3 or more (16% versus 25%, P = 0.757) or hospital stay (12 versus 17 days, P = 0.777). Most patients with elevated drain lipase levels had an unaltered clinical course not predictive of adverse outcomes. However, the operative finding of a soft pancreas (27 out of 57 patients) was associated with post-operative complications (P = 0.002). There were no peri-operative deaths. Conclusions Fibrin glue application to all anastomoses does not alter drain lipase levels. Drain lipase levels are not a significant surrogate marker for clinically significant anastomotic leaks or complications. Fibrin glue application did not reduce the incidence of an anastomotic leak or complications.
机译:背景技术这项研究的目的是评估在胰十二指肠切除术(PD)后在所有吻合处外用纤维蛋白胶对引流脂肪酶水平,吻合口漏,并发症发生率和住院时间的影响。方法对每个吻合口进行标准化或非保留性的非幽门螺杆菌PD治疗。结果57例患者被随机分组​​:32例有TISSEEL,25例无TISSEEL。各组在引流脂肪酶水平(高40%对43%,P = 0.794),包括胃或胆道渗漏的并发症(24%对28%,P = 1.00),伤口感染(16%)方面无统计学差异。相对于9%,P = 0.28)或Clavien得分为3或更高(16%对25%,P = 0.757)或住院时间(12天对17天,P = 0.777)。大多数引流脂肪酶水平升高的患者的临床病程没有改变,不能预示不良结果。然而,手术中发现软胰腺(57例中有27例)与术后并发症相关(P = 0.002)。没有围手术期死亡。结论将纤维蛋白胶应用于所有吻合口并不会改变引流脂肪酶水平。排泄脂肪酶水平不是临床上明显的吻合口漏出或并发症的重要替代指标。纤维蛋白胶的应用并没有减少吻合口漏或并发症的发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号